id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DOT-OST-2002-12555-0308,DOT,DOT-OST-2002-12555,"American Airlines, Inc.",Other,Correspondence,2026-12-13T05:00:00Z,2026,12,2025-10-28T04:00:00Z,,2026-02-14T13:14:34Z,,1,0,09000064b9056fb2
EPA-HQ-OW-2026-2575-0001,EPA,EPA-HQ-OW-2026-2575,Memo Opening Docket for Comments,Other,Memorandum to Open a Docket,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,2026-07-15T03:59:59Z,2026-05-15T16:15:09Z,,1,0,09000064b92d6152
FDA-2025-V-0353-0004,FDA,FDA-2025-V-0353,Amendment to variance from Something Good,Other,Amendment,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T20:51:22Z,,0,0,09000064b92da646
FDA-2026-H-5254-0001,FDA,FDA-2026-H-5254,Complaint,Other,Complaint,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T19:53:37Z,,0,0,09000064b92da640
FDA-2026-H-5253-0001,FDA,FDA-2026-H-5253,Complaint,Other,Complaint,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T21:37:53Z,,0,0,09000064b92da628
FDA-2025-P-7006-0009,FDA,FDA-2025-P-7006,"Final Response Letter from FDA CDER to Hyman, Phelps & McNamara, P.C.",Other,Grant of Petition,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T16:56:08Z,,0,0,09000064b92d515d
FDA-2026-H-5252-0001,FDA,FDA-2026-H-5252,Complaint,Other,Complaint,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T18:15:10Z,,0,0,09000064b92da5cd
FDA-2026-H-5255-0001,FDA,FDA-2026-H-5255,Complaint,Other,Complaint,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T19:33:46Z,,0,0,09000064b92db377
FDA-2026-H-5250-0001,FDA,FDA-2026-H-5250,Complaint,Other,Complaint,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T21:35:08Z,,0,0,09000064b92dadef
FDA-2026-H-5248-0001,FDA,FDA-2026-H-5248,Complaint,Other,Complaint,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T22:57:37Z,,0,0,09000064b92db36c
FDA-2025-P-6262-0052,FDA,FDA-2025-P-6262,Interim Response,Other,Letter(s),2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T20:28:02Z,,0,0,09000064b92dbaa6
FDA-2026-H-5251-0001,FDA,FDA-2026-H-5251,Complaint,Other,Complaint,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T18:18:45Z,,0,0,09000064b92da5f9
FDA-2026-H-5249-0001,FDA,FDA-2026-H-5249,Complaint,Other,Complaint,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T18:10:17Z,,0,0,09000064b92da5b9
FDA-2026-H-5256-0001,FDA,FDA-2026-H-5256,Complaint,Other,Complaint,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T21:26:05Z,,0,0,09000064b92db9f3
FDA-2026-H-5257-0001,FDA,FDA-2026-H-5257,Complaint,Other,Complaint,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-15T23:01:41Z,,0,0,09000064b92dadf5
FDA-2025-P-6024-0008,FDA,FDA-2025-P-6024,Final Response,Other,Denial,2026-05-15T04:00:00Z,2026,5,2026-05-15T04:00:00Z,,2026-05-16T01:50:33Z,,0,0,09000064b92dc6f6
EPA-HQ-OPP-2025-0177-0006,EPA,EPA-HQ-OPP-2025-0177,Public Participation for the new active ingredients collectively referred to as CTV-SoD2 variants.,Other,Public Participation,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,2026-05-30T03:59:59Z,2026-05-14T16:37:50Z,,1,0,09000064b92d6cc7
EPA-HQ-OPPT-2025-3358-0006,EPA,EPA-HQ-OPPT-2025-3358,Memo to Docket to Open Docket for Comment on Available Candidates (15-day public comment period),Other,Memorandum to Open a Docket,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,2026-05-30T03:59:59Z,2026-05-15T02:12:13Z,,1,0,09000064b92d9d6f
FDA-2022-V-0385-0004,FDA,FDA-2022-V-0385,Variance Renewal Application from Brant Parrish,Other,Application for Variance (VAR),2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T18:02:11Z,,0,0,09000064b92d6cc8
FDA-2026-P-5454-0002,FDA,FDA-2026-P-5454,Acknowledgment Letter from FDA DMB to Americans for Scientific Integrity,Other,Acknowledgement Letter/Receipt,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T17:41:43Z,,0,0,09000064b92d4fe9
FDA-2026-P-5454-0001,FDA,FDA-2026-P-5454,Citizen Petition from Americans for Scientific Integrity,Other,Citizen Petition,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T17:41:38Z,,1,0,09000064b92d4fe7
FDA-2025-P-6350-0004,FDA,FDA-2025-P-6350,Interim Response Letter from FDA CBER to Jack Weis,Other,Response(s),2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T18:12:30Z,,0,0,09000064b92d7d0a
FDA-2026-P-5578-0001,FDA,FDA-2026-P-5578,Suitability Petition from Appco Pharma LLC,Other,Petition(s),2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T23:17:53Z,,1,0,09000064b92d8f5b
FDA-2026-H-5193-0001,FDA,FDA-2026-H-5193,Complaint,Other,Complaint,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-15T00:35:04Z,,0,0,09000064b92d79e2
FDA-2026-H-5184-0001,FDA,FDA-2026-H-5184,Complaint,Other,Complaint,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T19:33:28Z,,0,0,09000064b92d6ce9
FDA-2026-H-5191-0001,FDA,FDA-2026-H-5191,Complaint,Other,Complaint,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T20:05:30Z,,0,0,09000064b92d6cee
FDA-2020-V-0476-0004,FDA,FDA-2020-V-0476,Variance Renewal Application from Andrew Stuart,Other,Application for Variance (VAR),2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T18:05:51Z,,0,0,09000064b92d76f8
FDA-2026-P-5578-0002,FDA,FDA-2026-P-5578,Acknowledgement Letter from FDA DMB to Appco Pharma LLC,Other,Acknowledgement Letter/Receipt,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T23:17:57Z,,0,0,09000064b92d8f63
FDA-2026-P-5611-0002,FDA,FDA-2026-P-5611,"Acknowledgment Letter from FDA DMB to Senores Pharmaceuticals, Inc",Other,Acknowledgement Letter/Receipt,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T23:37:28Z,,0,0,09000064b92d7cce
FDA-2026-P-3630-0006,FDA,FDA-2026-P-3630,Completeness Assessment Correspondence,Other,Assessment Document or Analysis,2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T15:19:06Z,,0,0,09000064b92d613f
FDA-2026-P-5611-0001,FDA,FDA-2026-P-5611,"Suitability Petition from Senores Pharmaceuticals, Inc",Other,Petition(s),2026-05-14T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T23:37:18Z,,1,0,09000064b92d9592
FDA-2026-H-4962-0001,FDA,FDA-2026-H-4962,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T16:11:53Z,,0,0,09000064b92d2875
FDA-2018-N-4626-1057,FDA,FDA-2018-N-4626,Nomination from Stokes Pharmacy,Other,Nomination,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T22:53:42Z,,0,0,09000064b92a502f
FDA-2019-D-1536-0037,FDA,FDA-2019-D-1536,Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework Guidance for Industry; Draft Guidance,Other,Guidance,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T15:23:30Z,,1,0,09000064b92d0c28
FDA-2026-H-4964-0001,FDA,FDA-2026-H-4964,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T20:07:19Z,,0,0,09000064b92d474c
FDA-2026-H-5121-0001,FDA,FDA-2026-H-5121,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-14T00:04:07Z,,0,0,09000064b92d4ee4
FDA-2026-H-5050-0001,FDA,FDA-2026-H-5050,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-14T00:06:15Z,,0,0,09000064b92d4ce2
FDA-2026-H-5126-0001,FDA,FDA-2026-H-5126,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T20:18:06Z,,0,0,09000064b92d58d5
FDA-2023-D-0608-0005,FDA,FDA-2023-D-0608,Development of Local Anesthetic Drug Products With Prolonged Duration of Effect; Guidance for Industry; Draft Guidance,Other,Guidance,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T15:22:13Z,,1,0,09000064b92d0c40
FDA-2026-H-4823-0001,FDA,FDA-2026-H-4823,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T18:56:10Z,,0,0,09000064b92d46ee
FDA-2026-H-4794-0001,FDA,FDA-2026-H-4794,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T20:54:18Z,,0,0,09000064b92d44cd
FDA-2026-H-5053-0001,FDA,FDA-2026-H-5053,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T23:02:35Z,,0,0,09000064b92d4bbf
FDA-2021-N-0556-0026,FDA,FDA-2021-N-0556,Development of Non-Opioid Analgesics for Acute Pain; Guidance for Industry; Draft Guidance,Other,Guidance,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T15:20:57Z,,1,0,09000064b92d0c73
FDA-1995-S-0036-0241,FDA,FDA-1995-S-0036,Public Disclosure from Boston Children's Hospital,Other,Public Disclosure,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T17:49:22Z,,0,0,09000064b92d4423
FDA-2026-H-4965-0001,FDA,FDA-2026-H-4965,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T20:09:56Z,,0,0,09000064b92d40a7
FDA-2026-R-5127-0001,FDA,FDA-2026-R-5127,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T22:53:38Z,,0,0,09000064b92d4bbc
FDA-2026-H-5052-0001,FDA,FDA-2026-H-5052,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-14T04:00:00Z,,2026-05-14T20:19:23Z,,0,0,09000064b92d4ce8
FDA-2023-D-1848-0023,FDA,FDA-2023-D-1848,Stimulant Use Disorders: Developing Drugs for Treatment; Guidance for Industry; Draft Guidance,Other,Guidance,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T15:18:07Z,,1,0,09000064b92d0c8f
FDA-2025-D-0610-0125,FDA,FDA-2025-D-0610,Development of Non-Opioid Analgesics for Chronic Pain; Guidance for Industry; Draft Guidance,Other,Guidance,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T15:19:21Z,,1,0,09000064b92d0c87
FDA-2026-P-5453-0002,FDA,FDA-2026-P-5453,Acknowledgement Letter from FDA DMB to Harmed Americans for Reform in Medical-Device Safety Corp. (HARMS),Other,Acknowledgement Letter/Receipt,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T23:04:37Z,,0,0,09000064b92d5159
FDA-2026-H-5054-0001,FDA,FDA-2026-H-5054,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T23:14:35Z,,0,0,09000064b92d4ee9
FDA-2026-H-5125-0001,FDA,FDA-2026-H-5125,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-14T00:06:58Z,,0,0,09000064b92d599b
FDA-2026-H-4827-0001,FDA,FDA-2026-H-4827,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T19:16:50Z,,0,0,09000064b92d4469
FDA-2026-H-4955-0001,FDA,FDA-2026-H-4955,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T18:58:41Z,,0,0,09000064b92d443b
FDA-2025-H-3115-0002,FDA,FDA-2025-H-3115,Amended Complaint,Other,Amendment,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T18:31:59Z,,0,0,09000064b92d2a7a
FDA-2026-H-4952-0001,FDA,FDA-2026-H-4952,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T19:14:34Z,,0,0,09000064b92d445b
FDA-2026-P-5453-0001,FDA,FDA-2026-P-5453,Citizen Petition from Harmed Americans for Reform in Medical-Device Safety Corp. (HARMS),Other,Citizen Petition,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T23:00:37Z,,1,0,09000064b92d5158
FDA-2026-H-5051-0001,FDA,FDA-2026-H-5051,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T20:57:05Z,,0,0,09000064b92d44db
FDA-2026-H-4992-0001,FDA,FDA-2026-H-4992,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T19:45:07Z,,0,0,09000064b92d3805
FDA-2026-H-5120-0001,FDA,FDA-2026-H-5120,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T23:42:26Z,,0,0,09000064b92d1f55
FDA-2026-H-5124-0001,FDA,FDA-2026-H-5124,Complaint,Other,Complaint,2026-05-13T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-14T00:00:28Z,,0,0,09000064b92d57b8
EPA-R08-OAR-2025-0230-0022,EPA,EPA-R08-OAR-2025-0230,WBI Hardin CS MNSR Final Permit MNSR-C-000001-2025.001,Other,,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-13T00:01:48Z,,0,0,09000064b92d1e32
FDA-2026-V-3076-0001,FDA,FDA-2026-V-3076,Variance Application from Ole Red Nashville,Other,Application for Variance (VAR),2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-13T00:06:06Z,,0,0,09000064b92363f7
FDA-2026-H-4796-0001,FDA,FDA-2026-H-4796,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T21:11:07Z,,0,0,09000064b92d2d04
FDA-2026-H-4990-0001,FDA,FDA-2026-H-4990,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:52:33Z,,0,0,09000064b92d40fa
FDA-2026-H-4795-0001,FDA,FDA-2026-H-4795,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:55:11Z,,0,0,09000064b92d5100
FDA-2026-H-4789-0001,FDA,FDA-2026-H-4789,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:48:22Z,,0,0,09000064b92d31ec
FDA-2026-D-5083-0002,FDA,FDA-2026-D-5083,Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization - Guidance for Industry,Other,Guidance,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T17:54:03Z,,1,0,09000064b92d0add
FDA-2025-P-6315-0013,FDA,FDA-2025-P-6315,Interim Response,Other,Letter(s),2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T18:26:15Z,,0,0,09000064b92cfe1a
FDA-2026-H-4831-0001,FDA,FDA-2026-H-4831,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T22:44:00Z,,0,0,09000064b92ca94e
FDA-2026-H-4970-0001,FDA,FDA-2026-H-4970,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:50:58Z,,0,0,09000064b92d307b
FDA-2026-H-4966-0001,FDA,FDA-2026-H-4966,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:30:43Z,,0,0,09000064b92d3801
FDA-2026-H-4731-0001,FDA,FDA-2026-H-4731,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T21:08:54Z,,0,0,09000064b92d18ad
FDA-2025-P-6094-0013,FDA,FDA-2025-P-6094,Interim Response,Other,Letter(s),2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T18:33:39Z,,0,0,09000064b92cf88c
FDA-2026-H-4991-0001,FDA,FDA-2026-H-4991,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:53:15Z,,0,0,09000064b92d5568
FDA-2026-H-4328-0001,FDA,FDA-2026-H-4328,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:56:11Z,,0,0,09000064b92d40fd
FDA-2026-H-4988-0001,FDA,FDA-2026-H-4988,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:51:47Z,,0,0,09000064b92d40e3
FDA-2026-H-4967-0001,FDA,FDA-2026-H-4967,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:37:33Z,,0,0,09000064b92d2f43
FDA-2026-V-3076-0003,FDA,FDA-2026-V-3076,Variance Approval Letter to Ole Red Nashville,Other,Approval for Variance (VRA),2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-13T00:06:16Z,,0,0,09000064b92d2807
FDA-2026-H-4728-0001,FDA,FDA-2026-H-4728,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T19:35:36Z,,0,0,09000064b92c8eff
FDA-2026-H-4961-0001,FDA,FDA-2026-H-4961,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-13T00:23:29Z,,0,0,09000064b92d18ff
FDA-2026-V-3076-0002,FDA,FDA-2026-V-3076,Acknowledgment Letter from FDA DMB to Ole Red Nashville,Other,Acknowledgement Letter/Receipt,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-13T00:06:11Z,,0,0,09000064b92363f8
FDA-2026-H-4824-0001,FDA,FDA-2026-H-4824,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T22:57:13Z,,0,0,09000064b92d0165
FDA-2026-H-4793-0001,FDA,FDA-2026-H-4793,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T19:29:33Z,,0,0,09000064b92c91b6
FDA-2026-H-4820-0001,FDA,FDA-2026-H-4820,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T21:13:18Z,,0,0,09000064b92d016d
FDA-2026-H-4821-0001,FDA,FDA-2026-H-4821,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T22:39:33Z,,0,0,09000064b92d015a
FDA-2026-P-4535-0006,FDA,FDA-2026-P-4535,"Completeness Assessment Correspondence to Hyman, Phelps & McNamara, P.C.",Other,Assessment Document or Analysis,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T20:51:56Z,,0,0,09000064b92d0cec
FDA-2026-H-4968-0001,FDA,FDA-2026-H-4968,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-13T00:32:19Z,,0,0,09000064b92d2f3b
FDA-2026-H-4969-0001,FDA,FDA-2026-H-4969,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-13T00:34:14Z,,0,0,09000064b92d2f3e
FDA-2026-H-4825-0001,FDA,FDA-2026-H-4825,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T23:01:39Z,,0,0,09000064b92d0121
FDA-2026-H-4832-0001,FDA,FDA-2026-H-4832,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T23:59:18Z,,0,0,09000064b92d0909
FDA-2026-H-4951-0001,FDA,FDA-2026-H-4951,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-12T04:00:00Z,,2026-05-12T16:04:05Z,,0,0,09000064b92d01f9
FDA-2026-H-4989-0001,FDA,FDA-2026-H-4989,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:45:06Z,,0,0,09000064b92d4748
FDA-2026-H-4963-0001,FDA,FDA-2026-H-4963,Complaint,Other,Complaint,2026-05-12T04:00:00Z,2026,5,2026-05-13T04:00:00Z,,2026-05-13T21:50:02Z,,0,0,09000064b92d3f9c
FDA-2026-P-5194-0001,FDA,FDA-2026-P-5194,"Suitability Petition from Hyman, Phelps & McNamara, P.C.",Other,Petition(s),2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T21:16:58Z,,1,0,09000064b92ca97f
FDA-2026-P-5188-0001,FDA,FDA-2026-P-5188,Citizen Petition from Kirke’s Homemade Ice Cream,Other,Citizen Petition,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T21:47:10Z,,1,0,09000064b92cf32d
FDA-2026-V-3796-0002,FDA,FDA-2026-V-3796,Acknowledgment Letter from FDA CDRH to Bernhard Blazier,Other,Acknowledgement Letter/Receipt,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T20:05:28Z,,0,0,09000064b9258455
FDA-2026-V-3796-0001,FDA,FDA-2026-V-3796,Variance Application from Bernhard Blazier,Other,Application for Variance (VAR),2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T20:05:22Z,,0,0,09000064b9258451
FDA-2026-H-4953-0001,FDA,FDA-2026-H-4953,Complaint,Other,Complaint,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T20:49:00Z,,0,0,09000064b92d0153
FDA-2013-D-1319-0016,FDA,FDA-2013-D-1319,Pulmonary Tuberculosis: Developing Drugs for Treatment; Guidance for Industry,Other,Guidance,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T17:31:41Z,,1,0,09000064b92cf3cb